Article
The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties
27 Jul 2020
Abstract excerpt
The emergence of superbugs developing resistance to antibiotics and the resurgence of microbial infections have led scientists to start an antimicrobial arms race. In this context, we have previously identified an active RiPP, the Ruminococcin C1, naturally produced by Ruminococcus gnavus E1, a symbiont of the healthy human intestinal microbiota. This RiPP, subclassified as a sactipeptide, requires the host...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
